Epidemiology of lung function in a global severe asthma population
M. Wechsler (Denver, CO, United States of America), E. Wang (Denver, CO, United States of America), G. Canonica (Milan, Italy), E. Heffler (Milan, Italy), R. Jones (Plymouth, United Kingdom), J. Busby (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom), P. Pfeffer (London, United Kingdom), D. Jackson (London, United Kingdom), A. Menzies-Gow (London, United Kingdom), R. Costello (Dublin, Ireland), E. Machale (Dublin, Ireland), C. Rhee (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), N. Eleangovan (Cambridge, United Kingdom), L. Bulathsinhala (Cambridge, United Kingdom), I. Chaudhry (Cambridge, United Kingdom), R. Murray (Cambridge, United Kingdom), C. Price (Cambridge, United Kingdom), V. Carter (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), T. Tran (Gaithersburg, MD, United States of America), J. Zangrilli (Gaithersburg, MD, United States of America), D. Price (Cambridge, United Kingdom)
Source: International Congress 2019 – Clinical implications of asthma management
Session: Clinical implications of asthma management
Session type: Poster Discussion
Number: 5023
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Wechsler (Denver, CO, United States of America), E. Wang (Denver, CO, United States of America), G. Canonica (Milan, Italy), E. Heffler (Milan, Italy), R. Jones (Plymouth, United Kingdom), J. Busby (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom), P. Pfeffer (London, United Kingdom), D. Jackson (London, United Kingdom), A. Menzies-Gow (London, United Kingdom), R. Costello (Dublin, Ireland), E. Machale (Dublin, Ireland), C. Rhee (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), N. Eleangovan (Cambridge, United Kingdom), L. Bulathsinhala (Cambridge, United Kingdom), I. Chaudhry (Cambridge, United Kingdom), R. Murray (Cambridge, United Kingdom), C. Price (Cambridge, United Kingdom), V. Carter (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), T. Tran (Gaithersburg, MD, United States of America), J. Zangrilli (Gaithersburg, MD, United States of America), D. Price (Cambridge, United Kingdom). Epidemiology of lung function in a global severe asthma population. 5023
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Asthma control, severity and lung function impairment through network analysis in children Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015
The influence of growing up on a farm on adult allergy, asthma and lung function Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014
Low grade systemic inflammation and lung function outcomes in European adults from the global asthma and allergy network of excellence (GA2 LEN) follow-up survey Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014
Seasonal distribution of exacerbations in Dutch and Swiss COPD patients Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014
Poor perception of bronchoconstriction and hyperinflation and risk of acute asthma exaerbations: A data linkage analysis Source: International Congress 2016 – Functional assessment of the airways Year: 2016
COPD underestimation in an Italian general population sample Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006
Global and regional trends in mortality from chronic obstructive pulmonary disease: Their relation to poverty, smoking and population change Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014
Medical and demographic loss of population due to chronic obstructive pulmonary disease Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Occupational exposure to pesticides is associated with excess lung function decline in a general population Source: Annual Congress 2013 –From air pollution during pregnancy to respiratory diseases at work Year: 2013
Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Allergic comorbidities and lung function in adolescence - Data from the BAMSE cohort Source: International Congress 2015 – Paediatric asthma and allergy: epidemiology and risk factors Year: 2015
The effect of persistence of persistent childhood wheeze through adolescence on lung function at 18-years Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016
LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015
Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample Source: International Congress 2014 – Epidemiology of asthma Year: 2014
Characterization and functional progression of COPD in young adults (early COPD) Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course Source: Eur Respir J, 53 (4) 1801795; 10.1183/13993003.01795-2018 Year: 2019